Additionally, the ERS-related proteins were downregulated following anti-TNF-α and anti-IL-1β treatment, including those implicated in neurological disorders such as HYOU1 [68], PDIA4 [69], and PDIA3 [70]. Here, HYOU1 is linked to nervous system disorder.